AdvanSource Biomaterials Corporation (OTCQB:ASNB), a leading
developer of advanced polymer materials for a broad range of medical
devices, today announced the engagement of Mirus Securities Inc.
(“Mirus”). Mirus, an investment bank located in the metropolitan Boston
area with in-depth experience within the med-tech manufacturing space,
has been engaged for the purpose of providing guidance and assessing
strategic alternatives.
About Mirus Securities Inc.
Mirus Securities Inc. is a subsidiary of Mirus Capital Advisors which
provides investment banking solutions to corporations and business
owners in the health care, technology, business services, manufacturing,
consumer products, and resort and hospitality industries. Since 1987,
Mirus has provided corporate finance advisory services on engagements
including mergers, acquisitions, divestitures, recapitalizations and
valuations. More information about Mirus Securities, Inc. and Mirus
Capital Advisors may be found at www.merger.com.
About AdvanSource Biomaterials Corporation
AdvanSource Biomaterials Corporation manufactures advanced polymer
materials, which provide critical characteristics in the design and
development of medical devices. The Company’s biomaterials are used in
devices that are designed for treating a broad range of anatomical sites
and disease states. AdvanSource’s business model leverages its
proprietary materials science technology and manufacturing expertise in
order to expand its product sales and royalty and license fee income.
More information about AdvanSource is available at its website at www.advbiomaterials.com.
Forward-Looking Statements
AdvanSource Biomaterials Corporation believes that this press release
contains forward-looking statements as that term is defined in the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements are based on management’s current expectations and are
subject to risks and uncertainties that could cause results to differ
materially from the forward-looking statements. For further information
on such risks and uncertainties, you are encouraged to review the
Company’s filings with the Securities and Exchange Commission, including
its Annual Report on Form 10-K for the fiscal year ended March 31, 2015
and its Quarterly Report on Form 10-Q for the quarter ended June 30,
2015. The Company assumes no obligation to update any forward-looking
statements as a result of new information or future events or
developments, except as required by law.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20151203005414r1&sid=ntxv4&distro=nx&lang=en)
View source version on businesswire.com: http://www.businesswire.com/news/home/20151203005414/en/
Copyright Business Wire 2015